TY - JOUR
T1 - Treatment Modalities for Insomnia in Adults Aged 55 and Older: A Systematic Review of Literature from 2018 to 2023
AU - McPhillips, Miranda
AU - Petrovsky, Darina
AU - Lorenz, Rebecca
AU - Lee, Jiwon
AU - George, Tessy
AU - Smyth, Aisling
AU - Bubu, Omonigho
AU - Brewster, Glenna
N1 - Funding Information:
This work was supported by the National Institute of Health, National Institute for Nursing Research and National Institute on Aging: K23NR018487 to MVM, K23AG073618 to DVP, K23AG068534, L30-AG064670 to OMB, and K23AG070378 to GB. Additionally, support was provided by the Alzheimer’s Association (AARG-D-21–848397 to OMB, AARG-D-20–52123 to GB) and the BrightFocus Foundation (A2022033S to OMB).
Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024.
PY - 2024/6
Y1 - 2024/6
N2 - Purpose of Review: Insomnia is the most common sleep disorder experienced by older adults. There is a wide range of pharmacological and non-pharmacological treatment options in existing literature. The purpose of this systematic review was to synthesize randomized controlled trials of insomnia treatment modalities for adults aged 55 and older over the last 5 years. We searched four databases, and after screening, there were 34 full-text manuscripts that met the inclusion/exclusion criteria. Recent Findings: We found non-pharmacological interventions, including exercise and behavioral/psychoeducational therapies, remain effective and favorable. Complementary and alternative therapies ranged across studies and warrant further testing in larger, more diverse samples. Dual orexin receptor antagonist medications were tested in a few studies with positive benefits for sleep and minimal side effects. Finally, measures of insomnia/sleep disturbance outcomes varied among the studies, with the Pittsburgh Sleep Quality Index being used most frequently. Summary: Non-pharmacological interventions for insomnia in older adults are effective, and some newer medications may be safer, with less side effects, at managing insomnia in this population.
AB - Purpose of Review: Insomnia is the most common sleep disorder experienced by older adults. There is a wide range of pharmacological and non-pharmacological treatment options in existing literature. The purpose of this systematic review was to synthesize randomized controlled trials of insomnia treatment modalities for adults aged 55 and older over the last 5 years. We searched four databases, and after screening, there were 34 full-text manuscripts that met the inclusion/exclusion criteria. Recent Findings: We found non-pharmacological interventions, including exercise and behavioral/psychoeducational therapies, remain effective and favorable. Complementary and alternative therapies ranged across studies and warrant further testing in larger, more diverse samples. Dual orexin receptor antagonist medications were tested in a few studies with positive benefits for sleep and minimal side effects. Finally, measures of insomnia/sleep disturbance outcomes varied among the studies, with the Pittsburgh Sleep Quality Index being used most frequently. Summary: Non-pharmacological interventions for insomnia in older adults are effective, and some newer medications may be safer, with less side effects, at managing insomnia in this population.
KW - Cognitive behavioral therapy for insomnia
KW - Exercise
KW - Older adults
KW - Randomized controlled trial
KW - Sleep quality
UR - http://www.scopus.com/inward/record.url?scp=85185481130&partnerID=8YFLogxK
U2 - 10.1007/s40675-024-00285-w
DO - 10.1007/s40675-024-00285-w
M3 - Article
SN - 2198-6401
VL - 10
SP - 232
EP - 256
JO - Current Sleep Medicine Reports
JF - Current Sleep Medicine Reports
IS - 2
ER -